Friday, October 30, 2020

FDA Approves New Drug Treatment For Schizophrenia And Bipolar Disorder

Must Read

BARACK OBAMA : AMERICA WANTS ME BACK FOR A 3RD TERM

He was supposed to retire to a triumphant post-presidency. Then Trump happened. Now, as Jason Zengerle reports, Obama is...

Pennsylvania GOP Sen. Pat Toomey Won’t Run For Re-Election in 2022

Pennsylvania Republican Sen. Pat Toomey has announced that he will not run for reelection in 2022. “I will not be...

Barack Obama Reportedly Skeptical of Joe Biden’s 2020 White House Run

The presidential election is officially less than 30 days away. With that in mind, we thought it would be helpful...

The drug Latuda, which was approved in 2010 for treatment in U.S. patients with schizophrenia, has now gained approval by the Food and Drug Administration for the treatment of depressive episodes in patients with bipolar disorder. The drug will be used either by itself or in conjunction with other medications, such as lithium or valproate.

“These two approvals represent a significant milestone not only for Sunovion and DSP, but for the millions of Americans who are living with bipolar disorder and struggling to manage the symptoms of bipolar depression,” said Masayo Tada, Representative Director, President and Chief Executive Officer of Dainippon Sumitomo Pharma Co., Ltd., in a press statement. “We look forward to building on the strong foundation started in the United States to bring LATUDA to other markets around the world. In addition, we are preparing for Phase 3 clinical trials for bipolar I disorder (bipolar depression) in Japan, an important market for us, where Phase 3 clinical trials for schizophrenia are already underway.”

Latuda is an atypical antipsychotic, or second generation antipsychotic, that alleviates symptoms associated with schizophrenia, such as hallucinations and delusions, without the side effect of restlessness.The approval of the drug for major episodes of depression related to bipolar disorder was supported by two clinical trials, PREVAIL 1 and 2. The endpoint of both studies was a reduction in depressive symptoms as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) six weeks after initiation of the treatment.

Another measurement was a change in Clinical Global Impression-Bipolar Version-Severity of Illness (CGI-BP-S) scores at six weeks as well.”Patients with bipolar disorder spend the majority of their symptomatic time in the depressed phase of the illness. This phase most commonly results in impaired function, a remarkable decrease in quality of life and may lead to increased risk for attempted suicide,”

said Joseph Calabrese, M.D., Professor of Psychiatry and Director of the Mood Disorders Program at University Hospitals Case Medical Center, Case Western Reserve University.Bipolar-related depression results in mood swings and affects around 10.4 million American adults. Bipolar disorder is typically characterized by one major episode of manic or mixed manic/depressive episode, and afflicted people usually have one major depressive episode as well.

When symptoms arise, patients tend to have episodes of depression, rather than manic symptoms. When patients experience the depressive phase of the disease, they often have thoughts of worthlessness and death and attempt suicide. Other symptoms are insomnia, depressed mood, loss of interest or pleasure in activities, weight loss, and the inability to concentrate.Bipolar disorder is the sixth leading cause of disability in the world and one of the top 10 causes of disability in the U.S.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

BARACK OBAMA : AMERICA WANTS ME BACK FOR A 3RD TERM

He was supposed to retire to a triumphant post-presidency. Then Trump happened. Now, as Jason Zengerle reports, Obama is...

Pennsylvania GOP Sen. Pat Toomey Won’t Run For Re-Election in 2022

Pennsylvania Republican Sen. Pat Toomey has announced that he will not run for reelection in 2022. “I will not be running for reelection in 2022...

Barack Obama Reportedly Skeptical of Joe Biden’s 2020 White House Run

The presidential election is officially less than 30 days away. With that in mind, we thought it would be helpful to remind readers that despite...

LeBron James Walks Off Court With Time Left on Clock During NBA Finals

However, those who are watching got to see Los Angeles Lakers superstar LeBron James throw a hissy fit on Monday night after his team...

AOC Says Dems Must Consider Impeaching Trump, Barr To Stop Supreme Court Nomination

Impeachment would force the U.S. Senate to hold a trial at a time when it has precious few days left on its calendar to...
- Advertisement -

More Articles Like This